A clinical trial to compare the effect of nasal administration of 2 Ayurvedic medicated oil (Sadbindu taila and Mulakadi taila) in participants with Idiopathic Parkinsons disease

Efficacy of Nasya with Sadbindu taila against Mulakadi taila Nasya in Idiopathic Parkinsons disease - A Randomized Controlled Trial

Status

Recruiting

Phases

Phase 3

Study type

Observational

Source

CTRI

Registry ID

CTRI/2021/05/033656

Enrollment

Registered

2021-05-17

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease Health Condition 2: G20- Parkinsons disease

Interventions

Intervention1: Nasya: Procedure - Nasya Medicine- Sadbindu taila Dose- minimum 1ml/nostril maximum- 2ml/ nostril Duration- 7 days Control Intervention1: Nasya: Procedure-Nasya Medicine- Mulaka

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of Idiopathic Parkinsons disease Chronicity not more than 5 years Patients on stable medications for Idiopathic Parkinsons disease Stable co morbidities Individuals willing to give informed consent

Exclusion criteria

Exclusion criteria: Stages of 4 and 5 of Parkinsons diseases based on Hoehn and Yarh scale Secondary Parkinsonism Pregnant and lactating women

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Sadbindu taila nasya in improving motor functions of Idiopathic Parkinsons diseaseTimepoint: 0th day, 8th day and 15th day after completion of Nasya	—

Secondary

Measure	Time frame
improvement in quality of life of enrolled participantsTimepoint: 0th day, 8th day and 15th day after completion of Nasya	—

Countries

India

Contacts

Public ContactJigeesh PP

V P S V Ayurveda College

drjigeesh@gmail.com9447997436

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026